Introduction {#cesec10}
============

Schistosomiasis is a parasitic disease caused by infection with blood flukes of the genus *Schistosoma*.[@bib1] An estimated 800 million people are at risk of infection and more than 200 million people are infected.[@bib2] In 2016, the global burden of schistosomiasis was 1·86 million disability-adjusted life years.[@bib3] Over the past 15 years, substantial progress has been made in the control of schistosomiasis. There has been a shift from morbidity control towards elimination in selected areas and new targets have been issued by WHO: elimination of schistosomiasis as a public health problem (prevalence of heavy intensity infections below 1% in all sentinel sites) and interruption of transmission (reduction of incidence of infection to zero) in selected areas by 2025.[@bib1], [@bib4] The Zanzibar archipelago, offshore from Tanzania, is one of the first settings in sub-Saharan Africa targeted for elimination of urogenital schistosomiasis as a public health problem and interruption of transmission.

The cornerstone of schistosomiasis control is mass drug administration (MDA) with praziquantel, but moving towards elimination will require complementary measures.[@bib4], [@bib5], [@bib6] Suggested measures to reach interruption of transmission in selected areas where transmission is low and highly focal include intensified treatment (ie, treatment intervals shorter than 12 months and targeting not only school-aged but also preschool-aged children and adults, including women of reproductive age) plus intermediate host snail control, improvements in access to clean water, sanitation, and hygiene (WASH) to reduce and ideally impede the contamination of freshwater bodies, and interventions to assist people in changing their behaviour to prevent transmission and infection.[@bib4], [@bib7], [@bib8], [@bib9], [@bib10]

Research in context**Evidence before this study**Elimination of schistosomiasis has been shown to be feasible. In 2011, the 56th World Health Assembly called on all countries endemic for schistosomiasis to intensify control interventions and to strengthen surveillance, with the aim of eliminating the disease. In 2012, WHO set elimination of schistosomiasis as a public health problem and interruption of transmission in selected areas as targets for 2025. Countries having achieved interruption of transmission reported economic improvements, the integrated use of mass drug administration (MDA), intermediate host snail control, or improved access to clean water, sanitation, and hygiene. A large-scale concurrent research trial of strategies to control *Schistosoma mansoni* done in St Lucia from 1965 to 1981 showed best results when chemotherapy was supplemented by snail control or new household level water supplies. Meta-analyses highlight that control of intermediate host snails can contribute significantly to moving towards schistosomiasis elimination in high-risk areas. However, evidence for strategic decisions based on results from randomised trials is absent.**Added value of this study**We did a 5-year cluster-randomised trial to assess the effect of different interventions for elimination of urogenital schistosomiasis as a public health problem and interruption of transmission. Biannual MDA with praziquantel was offered to all age groups with the exception of children below the age of 3 years across the Zanzibar islands. New behavioural interventions were developed in a human centred design approach and applied in randomised communities. The capacity for snail control was established. In randomised communities, water bodies containing intermediate host snails were targeted by focal mollusciciding. Our trial showed that biannual MDA applied alone or in combination with snail control or behaviour change activities can substantially reduce the overall *Schistosoma haematobium* prevalence and infection intensity. Urogenital schistosomiasis was eliminated as a public health problem from Zanzibar in more than 90% of the shehias included in the study, but transmission is not yet interrupted and reinfection occurs. Although randomised additional interventions in our study did not significantly boost the effect of MDA, they might enhance interruption of transmission when tailored to focal endemicity and applied for a longer period.**Implications of all the available evidence**Schistosomiasis is a focal disease. In settings where elimination as a public health problem and interruption of transmission is the goal, intervention strategies need to be tailored to the local micro-epidemiology and culture. It is now necessary to build on the experience gained in this trial and other studies, to focus on reducing prevalence and intensity in remaining hotspot areas, and to introduce new methods of rigorous surveillance, followed by specific public health response so that the important gains can be maintained and advanced.

Our objectives were to assess biannual MDA applied alone or with complementary snail control or behaviour change interventions for the reduction of *Schistosoma haematobium* prevalence and infection intensity in children from Zanzibar and to compare the effect between the clusters.

Methods {#cesec20}
=======

Study design and participants {#cesec30}
-----------------------------

The Zanzibar archipelago consists of two main islands: Pemba and Unguja. Each island is divided into districts, which are subdivided into small administrative units called shehias. In 2012, the national census recorded 121 shehias in Pemba and 210 shehias in Unguja. The total population is estimated at 1·3 million. Urogenital schistosomiasis caused by infection with *S haematobium* has been highly prevalent in the past century, with prevalences exceeding 50% in some places, but was reduced to an overall prevalence below 10% in 2012.[@bib11], [@bib12], [@bib13], [@bib14] It is hence important to note that our trial was done in a setting that had been exposed to MDA with praziquantel for several years and that our baseline population in 2012 was mostly not naive to treatment.[@bib13]

The study was a 5-year cluster-randomised open-label trial with three intervention arms. The study design has been published elsewhere.[@bib15] We included children aged 9--12 years. From 2012 to 2017, annually, a single urine sample was collected from approximately 100 children aged 9--12 years in the main public primary school of each of the 90 study shehias. A shehia was defined as the cluster and intervention unit. The trial was done in 90 shehias on Pemba and Unguja, from Nov 1, 2011, through to Dec 31, 2017, and recruitment took place from Nov 2, 2011, until May 17, 2017. Interventions in all arms started within one year after the baseline survey in 2012 and were intensified until the endline survey in early 2017. The first community-wide treatment MDA round was conducted on April 28, 2012. Snail control started on Aug 1, 2012. Behaviour change interventions started in a phase-in approach from Nov 1, 2012.

Ethical approval was obtained from the Zanzibar Medical Research Ethics Committee in Stonetown, Zanzibar (ZAMREC; reference no. ZAMREC 0003/Sept/011), the Ethikkommission beider Basel (EKBB) in Basel, Switzerland (reference no. 236/11) and the Institutional Review Board of the University of Georgia in Athens, GA, USA (project no. 2012-10138-0). Written informed consent was obtained from the parents or guardians of participating children.

Randomisation and masking {#cesec40}
-------------------------

Stratified by island, shehias were randomly allocated to one of three intervention arms (ratio 1:1:1), as described elsewhere.[@bib15] In brief, 15 shehias on each island received biannual MDA with praziquantel administered by the Neglected Tropical Diseases (NTD) Programme of the Zanzibar Ministry of Health across the archipelago (arm 1); 15 shehias received snail control in addition to biannual MDA (arm 2); and 15 shehias received behaviour change interventions in addition to biannual MDA (arm 3). Owing to the nature of the intervention, neither participants nor field or laboratory personnel were blinded to the intervention arms.

Outcomes {#cesec50}
--------

The primary outcome was *S haematobium* infection prevalence and intensity in 9--12-year-old children in Zanzibar in 2017 after 5 years of follow-up at individual and cluster level. The primary outcome was reworded after registration of the study to meet the appropriate definition of a variable[@bib16] and to point out the main trial population. The change in the primary outcome was based on the recommendation of trialists who supported the preparation of the statistical analysis plan ([appendix](#sec1){ref-type="sec"}) and decided upon by the trial leadership and the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) secretariat. The decision to reword the primary outcome was done before the statistician had access to the data for analysis. Secondary outcomes including the *S haematobium* prevalence and intensity in first-year students and adults are presented elsewhere.[@bib17] No outcomes were excluded from the analyses.

Procedures {#cesec60}
----------

The baseline survey was done in the primary schools of the 90 study shehias in early 2012, with annual follow-up surveys done in early 2013, 2014, 2015, 2016, and 2017. The purpose and procedures of the study were explained to eligible children. Once we received the informed consent form signed by the parents or guardians, the participants were provided with a plastic container and instructions for urine collection between 09:00 h and 14:00 h the following day. A single urine sample from each participant was transferred to the laboratory of the NTD Programme in Unguja or to the Public Health Laboratory---Ivo de Carneri in Pemba. Each urine sample of sufficient quantity was visually examined for macrohaematuria, for microhaematuria by means of reagent strips (Haemastix; Siemens Healthcare Diagnostics GmbH, Camberley, Surrey, UK), and for *S haematobium* eggs, by means of the filtration method.[@bib17] 10% of all urine samples were re-read by a senior laboratory technician for quality control. In the months following the survey, MDA was done in schools and communities and praziquantel (40 mg/kg) was offered to the whole eligible population. Treatment coverage data were collected as described elsewhere in detail.[@bib18]

Praziquantel was administered biannually across both islands, in all shehias located in Pemba and Unguja, with the exception of the South district and the Urban A and B subdistricts in Unguja.[@bib17] In community-wide treatment (CWT), implemented twice per year from April, 2012 onward, praziquantel was distributed by trained community drug distributors (CDDs) to the whole eligible population, excluding children younger than 3 years, children treated during school-based treatment (SBT), severely sick people, and pregnant women.[@bib18] In additional SBT, implemented for the first time in MDA round 4, praziquantel was administered to schoolchildren by teachers by means of a dose pole and the intake of drugs was directly observed. Data on treatment coverage of CWT was collected from the records of CDDs and of SBT from teachers, by staff of the Zanzibar Ministry of Health. Our project staff collected additional data on treatment coverage and compliance during the annual cross-sectional surveys in schools and communities.[@bib16], [@bib18]

For snail control activities, human water contact sites (HWCSs) were identified in the 30 study shehias before and over the course of the trial with the help of local knowledge and information. Trained teams did surveys for intermediate host snails (*Bulinus* spp) at each HWCS multiple times per year outside of the heavy rainy season. For this purpose, approximately 15 m of the shoreline were measured and searched for snails of all species by two collectors for 15 min, using their hands and snail scoops.[@bib19] The molluscicide niclosamide (Bayluscide; donated by Bayer SAS, Monheim, Germany) was sprayed at HWCSs only if *Bulinus* spp were present.[@bib17] Niclosamide wettable powder was mixed with pond water (according to manufacturer\'s instructions) and applied to the shoreline around the HWCS with Hudson backpack sprayers or a petrol power spraying machine, depending on the environment. The HWCS\'s location, type, water chemistry, presence of snails, and niclosamide spraying were recorded at each survey.

Community co-designed behaviour change interventions were developed and implemented in the 30 study shehias in a staggered approach by trained teams.[@bib20] Classroom-based and school-wide intervention components were done by trained primary school teachers and religious school teachers using culturally tailored, interactive tools, materials, and engagement methods developed within the programme (eg, flipcharts, blood fluke pictures, snail boards, and self-drawing of schistosome life-cycles) to teach children about schistosomiasis transmission and prevention.[@bib20], [@bib21] Teachers and children did regularly, school-wide, Kichocho Day Events incorporating dramas, poems, and games that focused on schistosomiasis transmission, prevention, and treatment. Parents and other community members were encouraged to participate in Kichocho Day Events and interactive health education activities. Community-based interventions included community meetings, evening educational films, and the construction of one male and one female urinal per shehia near a freshwater body with known schistosomiasis transmission. In the second half of the project, community co-designed washing platforms were constructed in close proximity to a safe water source in behavioural shehias with the highest disease prevalence. Data on school census and children exposed to the interventions as well as community intervention components were collected over the course of the implementation process.

Statistical analysis {#cesec70}
--------------------

The sample size calculation, eligibility criteria, and randomisation procedures of clusters and study participants are described in the published study protocol.[@bib15] In brief, to reach a desired power of 80%, the sample size of clusters (ie, shehias) exceeded the total number of schistosomiasis-endemic shehias in Unguja and Pemba and the sample size of participants was logistically not feasible. Hence, the choice of 15 shehias per intervention arm per island, and the number of people to be tested was a compromise between what was considered optimal and what was practically achievable. Participants were considered *S haematobium*-positive if the urine filtration method revealed at least one *S haematobium* egg per 10 mL urine, or, in the absence of a urine filtration result, if microhaematuria was detected with reagent strips. Infection intensities were classified into light (1--49 eggs per 10 mL urine) and heavy (≥50 eggs per 10 mL urine) according to WHO thresholds.[@bib22] Egg counts were truncated at 1000 eggs per 10 mL urine.

The absolute and relative difference (% change) in the *S haematobium* prevalence at baseline in 2012 and endline in 2017 were calculated. Arithmetic mean (AM) egg counts, including zeros, were calculated at baseline and endline as a proxy for transmission force at shehia level; AM egg counts, excluding zeros, were calculated at baseline and endline as a proxy for transmission force at individual level. The AM egg reduction rate from 2012 to 2017 was calculated by means of the following formula: 1--AM egg counts in 2017/AM egg counts in 2012. Generalised estimating equation models with binary logit functions and negative binomial distributed outcomes with log link functions, and independent correlation structure were applied to compare trial arms. All models used robust variance estimators to account for correlation within clusters (ie, the school). Biannual MDA alone was the designated reference group. For unadjusted estimates, only infection status (as outcome) and treatment arm were included in the model. In the adjusted analysis, sex and age were included in the model as explanatory variables. In addition, the observations in the adjusted analysis were weighted by the inverse cluster size (probability weights), which ensures that each cluster contributes equally to the generalised estimating equation, regardless of its size. Intra-class correlation was established by means of mixed models consistent with the generalised estimating equation, setup in the primary analysis.

Given the relatively high number of clusters, balance in baseline characteristics was a reasonable assumption. Since we detected some discrepancy in baseline prevalence among the three trial arms, we complemented the results with an exploratory analysis using different types of adjustment for baseline prevalence. Treatment coverage was calculated as described elsewhere in detail.[@bib18]

Descriptive statistics were done by means of Stata IC 14 (StataCorp; College Station, TX, USA), the primary analyses and interaction models by SAS version 9.4 and the inverse probability weight model was fitted by the ipw package of R version 3.4.3 by two of the authors (SK and JH).

The study is registered with the ISRCTN, number 48837681.

Role of the funding source {#cesec80}
--------------------------

The SCORE secretariat was involved in the trial design. The funder of the study had no role in data collection, data analysis, data interpretation, patient recruitment, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.

Results {#cesec90}
=======

The study flow and baseline characteristics are indicated in [figure 1](#fig1){ref-type="fig"}. The timeline and frequency of all interventions and surveys are illustrated in [figure 2](#fig2){ref-type="fig"}. 291 shehias were assessed for eligibility and 45 shehias on each island were randomly allocated to one of three study arms. At baseline, 2853 schoolchildren aged 9--12 years were surveyed from 30 schools in arm 1, 2688 children from 29 schools in arm 2, and 2613 children from 29 schools in arm 3. In arms 2 and 3, a non-randomised school was surveyed, and hence, excluded from further analyses. At the endline survey, 3184 children aged 9--12 years were surveyed from 30 schools in arm 1, 3217 children from 30 schools in arm 2, and 3080 children from 29 schools in arm 3. In arm 3, one school was lost to follow-up since it was transformed into a secondary school. [Table 1](#tbl1){ref-type="table"} indicates between-group differences of the *S haematobium* prevalence in arm 1 (4·2%) and in arm 2 (7·8%), or in arm 3 (6·4%), of the AM egg counts per 10 mL urine in arm 1 (2·8 eggs) and in arm 2 (5·7 eggs), or in arm 3 (5·3 eggs), and of the percentage of heavy infection intensities in arm 1 (0·9%) and in arm 2 (1·8%), or in arm 3 (2·0%). The trial arms were balanced with respect to age and sex of the participants.Figure 1Trial profileShehia=small administrative region. MDA=mass drug administration.Figure 2Timeline of interventions and surveysSBT=school-based treatment. CWT=community-wide treatment. \*In Pemba, in round 6, community-wide treatment was done by means of health posts.Table 1Baseline demographic and clinical characteristics**Biannual MDABiannual MDA plus snail controlBiannual MDA plus behaviour change**Schools[\*](#tbl1fn1){ref-type="table-fn"}302929Pemba151515Unguja151414Total participants289927412638Pemba1454 (50·2%)1308 (47·7%)1320 (50·0%)Unguja1445 (49·8%)1433 (52·3%)1318 (50·0%)Mean age in years (SD)10·5 (1·0)10·5 (1·0)10·5 (1·0)Pemba10·6 (0·9)10·7 (1·0)10·6 (1·0)Unguja10·4 (1·0)10·4 (1·0)10·4 (1·0)SexOverallGirls156914611410Boys133012801228PembaGirls822694720Boys632614600UngujaGirls747767690Boys698666628Participants with outcome data285326882613Pemba1437 (50·4%)1276 (47·5%)1304 (49·9%)Unguja1416 (49·6%)1412 (52·5%)1309 (50·1%)*Schistosoma haematobium* infection[†](#tbl1fn2){ref-type="table-fn"}120/2853 (4·2%)209/2688 (7·8%)167/2613 (6·4%)Pemba71/1437 (4·9%)141/1276 (11·1%)116/1304 (8·9%)Unguja49/1416 (3·5%)68/1412 (4·8%)51/1309 (3·9%)Arithmetic mean number of eggs per 10 mL of urine2·85·75·3Pemba5·010·29·6Unguja0·61·61·1Infection intensity[‡](#tbl1fn3){ref-type="table-fn"}OverallNegative2712/2830 (95·8%)2451/2658 (92·2%)2422/2585 (93·7%)Light93/2830 (3·3%)158/2658 (5·9%)111/2585 (4·3%)Heavy25/2830 (0·9%)49/2658 (1·8%)52/2585 (2·0%)PembaNegative1363/1433 (95·1%)1133/1274 (88·9%)1182/1297 (91·1%)Light47/1433 (3·3%)102/1274 (8·0%)70/1297 (5·4%)Heavy23/1433 (1·6%)39/1274 (3·1%)45/1297 (3·5%)UngujaNegative1349/1397 (96·5%)1318/1384 (95·2%)1240/1288 (96·2%)Light46/1397 (3·3%)56/1384 (4·0%)41/1288 (3·2%)Heavy2/1397 (0·1%)10/1384 (0·7%)7/1288 (0·5%)[^1][^2][^3][^4]

[Table 2](#tbl2){ref-type="table"} indicates the reduction in prevalence and intensity of infection. The overall *S haematobium* prevalence was reduced from 6·1% in 2012 to 1·7% in 2017, which represents a relative reduction of 72·3%. The percentage of schools with zero infections increased from 17 (19%) of 88 in 2012 to 42 (47%) of 89 in 2017. In 2017, prevalences within schools ranged from 0% to 10·7% (median 0·9%, IQR 0--2·4%). Although most of the 45 schools on each island considerably reduced the prevalence of *S haematobium* from 2012 to 2017, in some years and in some schools prevalences increased compared with the previous year ([figure 3](#fig3){ref-type="fig"}). The grand (mean of means) mean of the AM egg counts per 10 mL urine at school level was reduced from 4·7 eggs in 2012 to 1·2 eggs in 2017. The percentage of schools with heavy infection intensities affecting less than 1% of pupils increased from 54 (61%) of 88 in 2012 to 81 (91%) of 89 in 2017.Table 2Reduction of *Schistosoma haematobium* prevalence and intensity from baseline (2012) to endline (2017)**Biannual MDABiannual MDA plus snail controlBiannual MDA plus behaviour changeOverall**Clusters at baseline30292988Tested at baseline with urine filtration and reagent strips[\*](#tbl2fn1){ref-type="table-fn"}2853268826138154Tested at baseline with urine filtration[\*](#tbl2fn1){ref-type="table-fn"}2830265825858073Tested at baseline with reagent strips[\*](#tbl2fn1){ref-type="table-fn"}2852268126138146Infected at baseline[\*](#tbl2fn1){ref-type="table-fn"}120209167496Heavy infection intensity at baseline[†](#tbl2fn2){ref-type="table-fn"}254952126Prevalence at baseline[\*](#tbl2fn1){ref-type="table-fn"}4·2%7·8%6·4%6·1%Heavy infection intensity at baseline[†](#tbl2fn2){ref-type="table-fn"}0·9%1·8%2·0%1·6%Clusters at year 630302989Tested in year 6 with urine filtration and reagent strips[\*](#tbl2fn1){ref-type="table-fn"}3184321730809481Tested in year 6 with urine filtration[\*](#tbl2fn1){ref-type="table-fn"}3171321330789462Tested in year 6 with reagent strips[\*](#tbl2fn1){ref-type="table-fn"}3183319830789459Infected in year 6[\*](#tbl2fn1){ref-type="table-fn"}465658160Heavy infection intensity in year 6[†](#tbl2fn2){ref-type="table-fn"}1281333Prevalence in year 6[\*](#tbl2fn1){ref-type="table-fn"}1·4%1·7%1·9%1·7%Heavy infection intensity in year 6[†](#tbl2fn2){ref-type="table-fn"}0·4%0·3%0·4%0·4%Absolute difference between prevalence at year 6 and baseline[\*](#tbl2fn1){ref-type="table-fn"}−2·8−6·0−4·5−4·4Relative difference between prevalence in year 6 and baseline (% change)[\*](#tbl2fn1){ref-type="table-fn"}−65·7%−77·6%−70·5%−72·3%Village level arithmetic mean infection intensity at baseline (including zero egg counts)[†](#tbl2fn2){ref-type="table-fn"}2·86·35·04·7Village level arithmetic mean infection intensity at year 6 (including zero egg counts)[†](#tbl2fn2){ref-type="table-fn"}1·01·01·51·2Egg reduction rate (1--year 6 intensity at baseline)[†](#tbl2fn2){ref-type="table-fn"}0·60·80·70·8Individual-level arithmetic mean infection intensity at baseline (excluding zero egg counts)[†](#tbl2fn2){ref-type="table-fn"}68·073·584·675·9Individual-level arithmetic mean infection intensity at year 6 (excluding zero egg counts)[†](#tbl2fn2){ref-type="table-fn"}75·458·578·470·6[^5][^6][^7]Figure 3*Schistosoma haematobium* prevalence in 45 schools on each of the two study islands from 2012 to 2017Colours from red to green indicate the change in prevalence from high to low. Letters indicate the three different study arms. M=biannual praziquantel mass drug administration (MDA) only. B=behaviour change plus biannual praziquantel MDA. S=snail control plus biannual praziquantel MDA.

In 2017, the *S haematobium* prevalence decreased to 1·4% with MDA alone, 1·7% with MDA plus snail control, and 1·9% with MDA plus behaviour change. The generalised estimating equations revealed no significant differences between the prevalence of *S haematobium* with MDA plus snail control (odds ratio \[OR\] 1·21, 95% CI 0·6--2·7) or MDA plus behaviour change (OR 1·31, 95% CI 0·6--2·9) compared with biannual MDA alone ([table 3](#tbl3){ref-type="table"}). Similarly, no significant difference was observed between the infection intensity with MDA plus snail control (OR 0·93, 95% CI 0·3--3·3) or with MDA plus behaviour change (OR 1·44, 95% CI 0·4--4·4) compared with MDA alone. Adjusting for age, sex, and cluster weights did not change the point or interval estimates noteworthily ([table 3](#tbl3){ref-type="table"}). Intra-class correlation was estimated at 0·35.Table 3(Un)adjusted ORs of prevalence and count ratios for infection intensity**OR/CR95% CIp valuePrimary analysis**Prevalence 2017Unadjusted (n=9481)MDA1·0 (ref)\....MDA + snail control1·210·6--2·70·64MDA + behaviour change1·310·6--2·90·50Adjusted (n=9481)[\*](#tbl3fn1){ref-type="table-fn"}MDA1·0 (ref)\....MDA + snail control1·190·5--2·60·66MDA + behaviour change1·440·7--3·10·38Egg counts 2017Unadjusted (n=9462)MDA1·0 (ref)\....MDA + snail control0·930·3--3·30·91MDA + behaviour change1·350·4--4·40·62Adjusted (n=9462)[\*](#tbl3fn1){ref-type="table-fn"}MDA1·0 (ref)\....MDA + snail control0·960·3--3·30·94MDA + behaviour change1·800·6--6·00·32**Exploratory analysis**Prevalence 2012 *vs* 2017Intervention × year (n=17 635)[†](#tbl3fn2){ref-type="table-fn"}MDA1·0 (ref)\....MDA + snail control0·630·4--1·10·13MDA + behaviour change0·840·5--1·60·60Prevalence 2017Adjusted baseline prevalence (n=9250)MDA1·0 (ref)\....MDA + snail control0·640·3--1·30·17MDA + behaviour change0·820·4--1·90·65Inverse probability weights (n=9250)[‡](#tbl3fn3){ref-type="table-fn"}MDA1·0 (ref)\....MDA + snail control0·650·3--1·50·31MDA + behaviour change1·060·5--2·50·95[^8][^9][^10][^11]

The results of exploratory analysis by means of different models to adjust for imbalance in *S haematobium* prevalence at baseline suggested a greater effect of snail control compared with MDA alone with consistent OR estimates ranging from 0·63 to 0·65. However, 95% CIs were broad and the difference not significant ([table 3](#tbl3){ref-type="table"}). Likewise, behaviour change intervention showed slight improvements but the point estimates were less consistent and closer to unity (OR: 0·82--1·06).

In MDA rounds 1, 2, 3, and 5 on both islands and in Unguja also in round 6, children were targeted by CWT. [Table 4](#tbl4){ref-type="table"} shows that the coverage in these rounds, stratified by study arm, ranged from 63·8% to 86·6% as determined by NTD Programme staff. In rounds 4, 7, 8, 9, and 10 on both islands and in Pemba also in round 6, children received praziquantel by SBT. The coverage of SBT ranged from 72·2% to 90·4% when assessed by NTD Programme staff and from 69·8% to 98·1% in the trial coverage surveys.Table 4Praziquantel treatment coverage in 90 study schools and shehias**Shehias with schools**[\*](#tbl4fn1){ref-type="table-fn"}**School- children registered in school**[\*](#tbl4fn1){ref-type="table-fn"}**School-children treated**[\*](#tbl4fn1){ref-type="table-fn"}**School- children treated**[\*](#tbl4fn1){ref-type="table-fn"}**(%)School- children surveyed**[†](#tbl4fn2){ref-type="table-fn"}**School- children treated**[†](#tbl4fn2){ref-type="table-fn"}**School- children treated**[†](#tbl4fn2){ref-type="table-fn"}**(%)Shehias**[\*](#tbl4fn1){ref-type="table-fn"}**Total population**[\*](#tbl4fn1){ref-type="table-fn"}**Total population treated**[\*](#tbl4fn1){ref-type="table-fn"}**Total population eligible for treatment**[\*](#tbl4fn1){ref-type="table-fn"}**Total population treated**[\*](#tbl4fn1){ref-type="table-fn"}**(%)2012**MDA round 1MDA\...\...\...\.....31116 74699 187..85·0%MDA + snail control\...\...\...\.....31118 59697 744..82·4%MDA + behaviour change\...\...\...\.....30137 953105 450..76·4%MDA round 2MDA\...\...\...\.....31147 511122 100..82·8%MDA + snail control\...\...\...\.....31127 429104 634..82·1%MDA + behaviour change\...\...\...\.....30136 698118 409..86·6%**2013**MDA round 3MDA\...\...\...\.....30121 08988 26199 51172·9%MDA + snail control\...\...\...\.....31119 68191 732104 91876·6%MDA + behaviour change\...\...\...\.....30118 80987 221101 75273·4%MDA round 4MDA2518 02213 01172·2%3221236873·5%31151 77579 99395 44052·7%MDA + snail control2313 007974874·9%3262227669·8%31128 31188 621112 61569·1%MDA + behaviour change2425 28919 22076·0%3164253580·1%30127 39088 512108 16869·5%**2014**MDA round 5MDA\...\...\...\.....31128 38184 837100 02966·1%MDA + snail control\...\...\...\.....31135 07296 332115 55371·3%MDA + behaviour change\...\...\...\.....30139 88891 931116 21865·7%MDA round 6MDA1513 02311 15585·7%3276266181·2%1561 93240 41947 64465·3%MDA + snail control149775745776·3%3365270280·3%15103 44765 95080 31863·8%MDA + behaviour change1517 43314 05880·6%3230270983·9%1566 86445 48156 29068·0%**2015**MDA round 7MDA3137 37431 45484·2%\...\...31123 31768 23688 50155·3%MDA + snail control3140 96930 99975·7%\...\...31138 00083 869109 95760·8%MDA + behaviour change2940 65332 04578·8%\...\...30129 84275 64998 53958·3%MDA round 8MDA3149 36036 81074·6%3298305292·5%31106 99673 83293 54069·0%MDA + snail control3143 40532 94875·9%3398317293·3%31126 03489 604114 19771·1%MDA + behaviour change3047 70235 81875·1%3114287292·2%30114 03879 227101 87369·5%**2016**MDA round 9MDA3140 23335 03387·1%\...\...31120 17848 77984 30440·6%MDA + snail control3142 65335 99584·4%\...\...31128 34545 04590 30435·1%MDA + behaviour change3050 93042 86284·2%\...\...30115 16649 22283 80942·7%MDA round 10MDA3042 54538 43090·3%3192312697·9%31121 19074 97690 23461·9%MDA + snail control3045 66039 09885·6%3236315897·6%30138 817892 77107 04564·3%MDA + behaviour change3051 38646 46990·4%3093303498·1%30134 41079 97895 68959·5%[^12][^13][^14]

In the 15 shehias in Pemba, snail control was applied in a large and constant number of HWCSs identified and visited from 2012 until 2016 ([table 5](#tbl5){ref-type="table"}). Annual niclosamide coverage in HWCSs with *Bulinus* spp ranged from 84·0% to 97·6%. In Unguja, additional HWCSs were identified every year. Coverage of infested HWCSs ranged from 31·1% to 86·4%.Table 5Snail control coverage in 15 intervention shehias on each of the two study islands**20122013201420152016Unguja**Human water contact sites394091105111Human water contact sites with *Bulinus* spp29 (74·4%)22 (55·0%)47 (51·7%)35 (33·3%)50 (45·1%)Treated human water contact sites with niclosamide when *Bulinus* spp was found9 (31·1%)19 (86·4%)33 (70·2%)29 (82·9%)36 (72·0%)Total *Bulinus* spp collected1716565676221785Total *Bulinus* spp shedding0131705**Pemba**Human water contact sites140139143143139Human water contact sites with *Bulinus* spp45 (32·1%)46 (33·1%)45 (31·5%)42 (29·4%)29 (20·9%)Treated human water contact sites with niclosamide when *Bulinus* spp was found38 (84·0%)43 (93·5%)42 (93·3%)41 (97·6%)26 (89·7%)Total *Bulinus* spp collected25997887951012384Total *Bulinus* spp shedding44100

The school-based and classroom-based interventions for behaviour change reached annually several thousand children registered in schools or madrassas in Pemba and Unguja ([table 6](#tbl6){ref-type="table"}). The washing platforms installed in 2014 and 2015 were used frequently by all sexes and agegroups. The urinals were not frequently used, probably because of lack of maintenance by the community, and rapidly fell into disrepair.Table 6Behaviour change activities in 15 intervention schools and shehias on each of the two study islands**201220132014201520162017Total numbers for Pemba**Students registered in 15 public primary schools16 846NANANANA17 152School-based KDEs15151515150Students attending KDE 1--5KDE 1 (2012)14 364\...\...\....KDE 2 (2013)..14 120\...\.....KDE 3 (2014)\....15 232\...\...KDE 4 (2015)\...\...14 923\....KDE 5 (2016)\...\.....16 843..Classroom-based, interactive teachingNoYesYesYesYesYesCommunity-level behaviour change education meetings37304942490People attending meetings31603289558170714191..Urinals constructed0300000Urinals being usedNANANANANA5Washing platforms constructed006150..Washing platforms being used\....6212018[\*](#tbl6fn1){ref-type="table-fn"}Madrassa schools involved in intervention\....151554..Madrassa teachers trained in intervention\....535682..Madrassa students registered in exposed Madrassas\....359120665735..Madrassa KDEs\....151054..Madrassa students attending KDE 1--3KDE 1 (2014)\....3129\...\...KDE 2 (2015)\...\...923\....KDE 3 (2016)\...\.....4191..**Total numbers for Unguja**Students registered in 15 public primary schools14 887NANANANA12 314[†](#tbl6fn2){ref-type="table-fn"}School-based KDEs616151213..Students attending KDE 1--7KDE 1 (2012)5995\...\...\....KDE 2 (2013)..6358\...\.....KDE 3 (2013)..6248\...\.....KDE 4 (2014)\....13 309\...\...KDE 5 (2014)\....12 625\...\...KDE 6 (2015)\...\...9886\....KDE 7 (2016)\...\.....9577..Classroom-based, interactive teachingNoYesYesYesYesYesCommunity-level behaviour change education meetings042416026..People attended meetings..98871432672580..Urinals constructed028000..Urinals being used..NANANA3..Washing platforms constructed003220..Washing platforms being used..NANANA19[‡](#tbl6fn3){ref-type="table-fn"}..Madrassa schools involved in intervention0001555..Madrassa teachers trained in intervention000100226..Madrassa students registered in exposed Madrassas\...\...45078647..Madrassa KDEs0002253..Madrassa students attending KDE 1--2KDE 1 (2015)\...\...4217\....KDE 2 (2016)\...\.....4106..[^15][^16][^17][^18]

Discussion {#cesec100}
==========

Over the past decades, examples from several countries and areas have shown that elimination of schistosomiasis is feasible. Countries having achieved interruption of transmission reported economic improvements, the integrated use of MDA, intermediate host snail control, or improved access to WASH.[@bib5] We assessed the effect of snail control and behaviour change interventions on top of biannual praziquantel MDA for the reduction of *S haematobium* prevalence and infection intensity among 9--12-year-old children from Zanzibar, one of the first settings in sub-Saharan Africa where interruption of transmission seems to be a feasible goal, in a 5-year repeated cross-sectional cluster-randomised open-label trial. Three key messages emerged from our results. First, biannual MDA alone or in combination with snail control or behaviour change interventions substantially reduced the overall *S haematobium* prevalence and infection intensities and eliminated schistosomiasis as a public health problem from most areas in Zanzibar. Second, biannual MDA was not sufficient to interrupt transmission in 5 years, even if accompanied by additional measures at small scale. Third, there was considerable spatial and temporal heterogeneity of infections.

Of note, although snail control or behaviour change activities did not significantly boost the effect of biannual MDA over the time of the project and at the scale used, they might contribute to further reducing prevalence and enhance interruption of transmission when tailored to focal endemicity, implemented with high coverage and good access to WASH, and applied for a longer period.

The following main challenges should be considered. Although MDA coverage was high in schools, it was low in the community. Non-covered or non-complying individuals might have served as a reservoir of infection contributing to continued transmission. Cure rate (73·6%) and egg reduction rate (94·7%) of praziquantel against *S haematobium* are not perfect.[@bib23] People are mobile and might have acquired infection in a neighbouring shehia without snail control interventions. Focal application and sporadic coverage of HWCSs with niclosamide to minimise environmental effect does not prevent snails from repopulating the treated freshwater bodies quickly, maintaining the possibility of parasite transmission. Behaviour change needs time to initiate and adopt, and requires access to child-friendly WASH.

Although not as obvious as persistent hotspots in other studies,[@bib24], [@bib25] some pockets with high risk of transmission remained on both islands. These were characterised by a large number of HWCSs containing intermediate host snails and being located in close proximity to schools or settlements.[@bib19], [@bib26] In such high-risk ecological settings, MDA alone might suppress transmission only partially.[@bib27] Continuing towards the end game of elimination, these areas will need targeted integrated interventions applied with high coverage. To prevent a re-emergence of infection in low-risk and zero-prevalence areas, new tools and strategies tailored to the changing endemic landscape that detect cases and transmission spots with a high sensitivity and trigger interventions that are accepted by a mostly non-infected community are needed. Moving from schistosomiasis control towards elimination as a public health problem and interruption of transmission will require an adaptive strategy, progressing from widespread MDA towards selective interventions and surveillance-response mechanisms.[@bib6], [@bib9], [@bib28], [@bib29] Translational research to assess the feasibility of combined interventions in hotspot and adequate surveillance-response approaches in low-endemicity areas might provide evidence on how to sustain and further advance the gains made to date, with the ultimate goal of reaching interruption of transmission.

Limitations of our study are that our intervention units were randomly allocated before and not after assessment of the baseline prevalence. Given the low prevalence at the endline survey, our trial was not powered to detect small but biologically important effects as significant differences. Owing to the very low number of positive individuals in this elimination setting, a sufficiently large cluster and participant number was operationally not feasible.[@bib17] Urine filtration and reagent strip methods are not highly sensitive, particularly if infection intensities are very light.[@bib30] Use of more rigorous diagnostic approaches and tests with higher sensitivity would probably have resulted in a higher *S haematobium* prevalence and a clearer picture of the real effect of interventions.[@bib31] Moreover, all of the interventions were implemented and intensified over time and readily available only in 2015. Since we did not assess the abundance and infection of intermediate host snails in shehias outside the snail control arm, it was not possible to compare the number of infected snails across the different arms. As streams and water bodies might run and extend through different shehias, a future control strategy for the whole island should consider treating HWCSs along the whole course of the water body irrespective of the shehia boundaries. Self-reported behaviour change was qualitatively assessed in children by visiting schools in arms 1, 2, and 3 through a mixed methods study at the end of the project (manuscript in preparation). Children targeted by behavioural interventions reported now taking praziquantel during MDA, and having stopped bathing and washing in the river more frequently than children from the other arms (manuscript in preparation). Hence, although no significant difference of added snail control or behavioural change interventions compared with MDA alone was detected in the extremely low *S haematobium* prevalences in our endline survey, the effect of these interventions might be reflected elsewhere.

Urogenital schistosomiasis was eliminated as a public health problem from Zanzibar in more than 90% of the shehias included in the study, but transmission is not yet interrupted and reinfection occurs. It is now necessary to build on the experience gained in the trial, to focus on reducing prevalence in the remaining hotspot areas by biannual MDA plus additional measures implemented with high coverage, and at the scale needed, and to introduce new surveillance-response approaches so that the important gains can be maintained and advanced.

For more on the **R Project** see <http://www.r-project.org>

Data sharing {#cesec110}
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Data collected for the study, anonymised participant data, and a data dictionary defining each field in the set, will be made available to others on reasonable request. De-identified participant data of the requested dataset plus a data dictionary will be made available on reasonable request. The following additional, related documents are published or will be available on reasonable request: published study protocol, statistical analysis plan, informed consent form. These data will be available with publication. The SCORE Data Request Form can be requested from the corresponding author. Data will be shared once the SCORE Data Request Form has been evaluated and signed by all relevant parties.
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[^1]: Data are number (%), or n/N (%), unless otherwise stated. MDA=mass drug administration. SD=standard deviation.

[^2]: One school in the biannual MDA plus snail control group and one school in the biannual MDA plus behaviour change group were not surveyed at baseline.

[^3]: *S haematobium*-positive is defined as urine filtration egg-positive or, in the absence of a urine filtration result, as haematuria-positive (trace, +, ++, and +++).

[^4]: The intensity of *S haematobium* infection was categorised as negative (0 eggs per 10 mL of urine), light (1--49 eggs per 10 mL of urine), or heavy (≥50 eggs per 10 mL of urine).

[^5]: MDA=mass drug administration.

[^6]: *Schistosoma haematobium*-positive is defined as urine filtration egg-positive or, in the absence of a urine filtration result, as haematuria-positive (trace, +, ++, and +++).

[^7]: The intensity of *S haematobium* infection was categorised as negative (0 eggs per 10 ml of urine), light (1--49 eggs per 10 mL of urine), or heavy (≥50 eggs per 10 mL of urine).

[^8]: OR=odds ratio. CR=count ratios.

[^9]: Sex and age are also included in the model, along with weighting for number of children who provided data, because not all schools were able to sample 100 children aged 9--12-years.

[^10]: Baseline year (2012) is the reference.

[^11]: Clusters are inversely weighted by their baseline prevalence as continuous variables.

[^12]: MDA=mass drug administration.

[^13]: Ministry of Health data.

[^14]: Cluster-randomised trial data. Coverage in school-based treatment and community-wide treatment in ten rounds of mass drug administration done from 2012 to 2017 was assessed by the Zanzibar Ministry of Health and within our cluster-randomised trial. Calculation of coverage is described in detail in Knopp et al 2016.[@bib18]

[^15]: NA=not assessed. KDE=Kichocho Day Event.

[^16]: Two washing platforms had no water and one needed minor repair.

[^17]: One public primary school closed before the end of the study and changed the school type to secondary school only.

[^18]: The six platforms were not used because the safe water source nearby was no longer functioning (wells dried; tap water has been cut).
